Table 1. Clinical and biochemical characteristics of primary liver cancer patients.
| References values | Cancer patients (n = 47) | |
|---|---|---|
| Clinical characteristics | ||
| Age, years | 67.1 ± 9.0 | |
| Gender, % male | 76.6% | |
| Smoking | 68.1% | |
| Alcohol drinking | 72.3% | |
| Laboratory tests | ||
| CRP (mg/L)* | <5 | 7.70 (5.13–11.55) |
| Hb (g/dL) | 13.5–16.0 | 13.5 ± 1.62 |
| MCV (fL) | 86–98 | 91.9 ± 7.49 |
| WBCs (109/L) | 4.3–10.0 | 7.01 ± 2.96 |
| PLTs (109/L) | 150–400 | 235.6 ± 119.9 |
| AST (U/L)* | 8–50 | 41.7 (32.8–53.2) |
| ALT (U/L)* | 8–45 | 40.8 (30.2–55.0) |
| ALP (U/L)* | 30–130 | 92.4 (77.9–109.6) |
| gGT (U/L)* | <50 | 76.7 (58.6–100.3) |
| Total bilirubin (mg/dL)* | 0.11–1.05 | 0.71 (0.59–0.86) |
| Direct bilirubin (mg/dL)* | <0.35 | 0.25 (0.20–0.31) |
| PT (INR)* | 0.82–1.14 | 1.11 (1.07–1.15) |
| Albumin (g/L) | 35–50 | 39.9 ± 5.54 |
| CHE (U/L) | 4650–14400 | 6515 ± 1890 |
| Total cholesterol (mg/dL) | <200 | 159.5 ± 48.9 |
| Triglycerides (mg/dL)* | <150 | 112.7 (100.1–126.7) |
| Creatinine (mg/dL)* | 0.59–1.29 | 0.86 (0.74–1.00) |
| Glucose (mmol/L) | 3.5–5.5 | 6.39 ± 1.81 |
| Folate (nmol/L)* | 10.4–42.4 | 8.52 (9.95–10.45) |
| tHcy (μg/L)* | < 15 | 13.2 (10.4–16.7) |
| Vitamin B12 (pmol/L)* | 142–724 | 337.0 (288.4–393.8) |
| Vitamin B6 (nmol/L)* | 25–128 | 19.7 (15.4–25.2) |
| Ferritin (μg/L)* | 30–400 | 249.4 (178.2–349.0) |
Values are expressed as mean ± SD.
*: log-transformed variables are shown as geometric mean with 95% confidence interval
Alcohol drinking defined as ≥ 36 g ethanol/day for males and ≥ 24 g ethanol/day for females
Abbreviations: CRP, C-reactive protein; Hb, Hemoglobin; MCV, Mean Corpuscular Volume; WBCs, White Blood Cells; PLTs, Platelets; AST, aspartate aminotransferase; ALT, aspartate alanine aminotransferase; ALP, Alkaline phosphatase; gGT, gamma glutamyl transferase; PT (INR), Prothrombin International Ratio; CHE, cholinesterase; tHcy, Homocysteine.